These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28829491)

  • 1. The effect of sitagliptin on obese patients with insulin treatment-induced diabetes mellitus.
    Li S; Li H; Wang R; Zhang JP
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3490-3495. PubMed ID: 28829491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of combination therapy of insulin glargine, metformin, and sitagliptin on insulin secretion, insulin resistance, and metabolic parameters in obese subjects with type 2 diabetes.
    Beljić-Živković T; Marjanović-Petković M; Vuksanović M; Soldatović I; Kanlić D; Topalov D
    Srp Arh Celok Lek; 2016; 144(9-10):497-502. PubMed ID: 29652465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease.
    Nar A; Gedik O
    Acta Diabetol; 2009 Jun; 46(2):113-8. PubMed ID: 18839053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus.
    Erdem G; Dogru T; Tasci I; Bozoglu E; Muhsiroglu O; Tapan S; Ercin CN; Sonmez A
    Diabetes Res Clin Pract; 2008 Nov; 82(2):214-8. PubMed ID: 18778865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients.
    Derosa G; Carbone A; Franzetti I; Querci F; Fogari E; Bianchi L; Bonaventura A; Romano D; Cicero AF; Maffioli P
    Diabetes Res Clin Pract; 2012 Oct; 98(1):51-60. PubMed ID: 22682949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.
    Yaikwawong M; Jansarikit L; Jirawatnotai S; Chuengsamarn S
    Nutr J; 2024 Oct; 23(1):119. PubMed ID: 39354480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple combination of insulin glargine, sitagliptin and metformin in type 2 diabetes: the EASIE post-hoc analysis and extension trial.
    Chan JC; Aschner P; Owens DR; Picard S; Vincent M; Dain MP; Pilorget V; Loizeau V; Echtay A; Fonseca V
    J Diabetes Complications; 2015; 29(1):134-41. PubMed ID: 25283485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramadan Intermittent Fasting Affects Adipokines and Leptin/Adiponectin Ratio in Type 2 Diabetes Mellitus and Their First-Degree Relatives.
    Abdullah K; Al-Habori M; Al-Eryani E
    Biomed Res Int; 2020; 2020():1281792. PubMed ID: 32775407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.
    Putz DM; Goldner WS; Bar RS; Haynes WG; Sivitz WI
    Metabolism; 2004 Nov; 53(11):1454-61. PubMed ID: 15536601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of exenatide and acarbose on intra-abdominal fat content in patients with obesity and type-2 diabetes: A randomized controlled trial.
    Shi L; Zhu J; Yang P; Tang X; Yu W; Pan C; Shen M; Zhu D; Cheng J; Ye X
    Obes Res Clin Pract; 2017; 11(5):607-615. PubMed ID: 28161303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.
    Charbonnel B; Karasik A; Liu J; Wu M; Meininger G;
    Diabetes Care; 2006 Dec; 29(12):2638-43. PubMed ID: 17130197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased insulin sensitivity in individuals with neurofibromatosis type 1.
    Martins AS; Jansen AK; Rodrigues LOC; Matos CM; Souza MLR; Miranda DM; Rezende NA
    Arch Endocrinol Metab; 2018 Feb; 62(1):41-46. PubMed ID: 29694637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sitagliptin/Metformin Versus Insulin Glargine Combined With Metformin in Obese Subjects With Newly Diagnosed Type 2 Diabetes.
    Ji M; Xia L; Cao J; Zou D
    Medicine (Baltimore); 2016 Mar; 95(11):e2961. PubMed ID: 26986104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of leptin, soluble leptin receptor, adiponectin and visfatin in insulin sensitivity in preterm born children in prepubertal ages.
    Yanni D; Darendeliler F; Bas F; Kucukemre Aydin B; Coban A; Ince Z
    Cytokine; 2013 Oct; 64(1):448-53. PubMed ID: 23726672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Dapagliflozin and Sitagliptin on Insulin Resistant and Body Fat Distribution in Newly Diagnosed Type 2 Diabetic Patients.
    Sun Y; Yan D; Hao Z; Cui L; Li G
    Med Sci Monit; 2020 Apr; 26():e921891. PubMed ID: 32240122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin.
    Yu M; Shankar RR; Zhang R; Zhang Y; Lin J; O'Neill EA; Chen G; Liu S; Tu Y; Engel SS
    Diabetes Obes Metab; 2019 Feb; 21(2):408-411. PubMed ID: 30178570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of the therapeutic effect of metformin monotherapy with metformin and acupuncture combined therapy on weight loss and insulin sensitivity in diabetic patients.
    Firouzjaei A; Li GC; Wang N; Liu WX; Zhu BM
    Nutr Diabetes; 2016 May; 6(5):e209. PubMed ID: 27136447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.